Spiro Rombotis
2020
In 2020, Spiro Rombotis earned a total compensation of $1.4M as President and Chief Executive Officer at Cyclacel Pharmaceuticals, a 39% increase compared to previous year.
Compensation breakdown
| Bonus | $201,610 |
|---|---|
| Option Awards | $637,000 |
| Salary | $530,553 |
| Other | $40,481 |
| Total | $1,409,644 |
Rombotis received $637K in option awards, accounting for 45% of the total pay in 2020.
Rombotis also received $201.6K in bonus, $530.6K in salary and $40.5K in other compensation.
Rankings
In 2020, Spiro Rombotis' compensation ranked 7,121st out of 13,090 executives tracked by ExecPay. In other words, Rombotis earned more than 45.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,121 out of 13,090 | 46th |
Division Manufacturing | 2,975 out of 5,618 | 47th |
Major group Chemicals And Allied Products | 1,199 out of 2,251 | 47th |
Industry group Drugs | 1,032 out of 1,951 | 47th |
Industry Pharmaceutical Preparations | 769 out of 1,456 | 47th |
Source: SEC filing on April 29, 2021.
Rombotis' colleagues
We found two more compensation records of executives who worked with Spiro Rombotis at Cyclacel Pharmaceuticals in 2020.
News
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2023 pay slips 13% to $661K
May 7, 2024
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2022 pay falls 43% to $764K
April 28, 2023
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2021 pay slips 5% to $1.3M
April 26, 2022
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2020 pay jumps 39% to $1.4M
April 29, 2021
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2019 pay jumps 35% to $1M
May 12, 2020